ResMed Inc. shares fall 2.40% for second day amid market downturn

9 articles · Updated · MarketWatch · Apr 29

ResMed Inc. stock closed at $211.93 on Wednesday, dropping 2.40% with trading volume reaching 1.3 million, above its 50-day average.
The decline outpaced the S&P 500’s 0.04% and Dow Jones’ 0.57% losses, marking ResMed’s second consecutive day of underperformance.
Shares now stand 27.87% below their 52-week high of $293.81 set on August 22, reflecting ongoing market pressure.

Why do analysts remain bullish on ResMed while its stock price continues to plummet?

Will ResMed's upcoming earnings report prove its resilience or confirm fears of a market disruption?

With rival Philips planning a return, is ResMed's long-held market dominance at risk?

Can ResMed's AI and data strategy overcome the challenge from revolutionary weight-loss drugs?

Are weight-loss drugs a death knell for CPAP therapy or an unexpected gateway to new patients?